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ChickenicroRNAs, miR-1, miR-206 and miR-133 is restricted to skeletal myoblasts and
cardiac tissue during embryo development and muscle cell differentiation, which suggests a regulation by
muscle regulatory factors (MRFs). Here we show that inhibition of C2C12 muscle cell differentiation by FGFs,
which interferes with the activity of MRFs, suppressed the expression of miR-1, miR-206 and miR-133. To
further investigate the role of myogenic regulators (MRFs), Myf5, MyoD, Myogenin and MRF4 in the
regulation of muscle speciﬁc microRNAs we performed gain and loss-of-function experiments in vivo, in
chicken and mouse embryos. We found that directed expression of MRFs in the neural tube of chicken
embryos induced ectopic expression of miR-1 and miR-206. Conversely, the lack of Myf5 but not of MyoD
resulted in a loss of miR-1 and miR-206 expression. Taken together our results demonstrate differential
requirements of distinct MRFs for the induction of microRNA gene expression during skeletal myogenesis.
© 2008 Elsevier Inc. All rights reserved.Introduction
The development and differentiation of muscle has been instru-
mental in understanding both how cells acquire their fate during
embryogenesis and how differentiation programmes are activated and
maintained (Buckingham et al., 2003; Tapscott, 2005).
microRNAs, small non-coding RNAs of between 18 and 22
nucleotides, have recently been identiﬁed as novel regulators of
gene expression. They negatively regulate genes by binding to speciﬁc
sequences in the 3′UTR of target genes and inhibiting their translation
(He and Hannon, 2004; Lai, 2002). microRNAs have been implicated in
a range of biological processes including cancer (Dalmay and Edwards,
2006; Zhang et al., 2007) development of the limb (Harfe et al., 2005;
Hornstein et al., 2005), lung (Harris et al., 2006) and haematopoetic
system (Chen et al., 2004). In addition, a number of microRNAs have
been characterised as modulators of myogenic differentiation (Callis
et al., 2007) and there is increasing evidence for microRNA involve-
ment in myopathies such as muscular dystrophies (Eisenberg et al.,
2007; McCarthy et al., 2007).ces, Cell and Developmental
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l rights reserved.Some of the best-characterisedmicroRNAs aremiR-1, miR-206 and
miR-133 (McCarthy, 2008; van Rooij et al., 2008). In situ hybridisation
studies suggest that skeletal muscle speciﬁc expression of these
microRNAs is conserved during Xenopus, zebraﬁsh, chicken and
mouse embryo development (Darnell et al., 2006; Sweetman et al.,
2006; Wienholds et al., 2005). Genome analyses have shown that in
human and mouse there are three loci encoding these microRNAs,
each of which produces a transcript containing one of the miR-1/206
family and one of the miR-133 family. In the chicken genome four loci
have been found, presumably resulting from a further duplication at
one of these loci (http://www.ensembl.org/index.html). A schematic
representation of these loci and alignments of the pre-microRNA and
mature microRNA sequences is shown (Fig. 1).
Experiments in cell culture suggested that miR-1 and miR-206
promote differentiation of myoblasts, while miR-133 promotes
proliferation through down-regulation of different target genes
(Chen et al., 2006; Kim et al., 2006). ChIP on CHIP analysis indicated
that the myogenic regulatory factors (MRF), MyoD andMyogenin bind
to sequences upstream of miR-1 and miR-133 (Rao et al., 2006).
Furthermore, MEF2, an essential regulator of skeletal muscle devel-
opment, plays a critical role in the control of an intragenic enhancer
located in the mir1–2 locus (Liu et al., 2007). We previously showed
that ectopic FGF suppresses miR-206 expression during somite
development. We provided evidence that miR-206 down-regulation
Fig. 1. Sequence alignments of chicken muscle speciﬁc microRNAs. (A) Four loci encode
the muscle speciﬁc microRNAs in the chicken on chromosomes 2, 3, 20 and 23. Each has
one member of the miR-1/206 family and one of the miR-133 family. (B) Alignments of
the pre-microRNAs produced from these loci and the mature microRNAs. The four loci
produce three distinct microRNAs as the mature microRNA sequences from miR-1a-1
and miR-1a-2 are identical as are those from miR-133a-1 and miR-133a-2. The red bar
indicates the seed sequences of these microRNAs.
492 D. Sweetman et al. / Developmental Biology 321 (2008) 491–499is mediated by inhibition of MyoD expression via ERK MAP kinase
(Sweetman et al., 2006). As yet however a deﬁnitive role of MRFs in
the regulation of microRNA expression during embryogenesis has not
been demonstrated.
To explore further the regulation of microRNA expression during
myogenesis we employed the skeletal muscle cell line C2C12, a
mesenchymal cell line that is widely used as an in vitro model for
muscle cell differentiation. Undifferentiated C2C12 cells express Myf5
and MyoD but not myogenin and Mrf4. Although it is generally
assumed that Myf5 andMyoD actively determine the committed state
of C2C12 cells the ability of theseMRFs to induce differentiation under
growth conditions is blocked. Only the removal of growth factors and/
or the down-regulation of growth factor receptors lead to myogenic
differentiation as marked by a strong increase of the expression of
myogenin and other muscle differentiation markers such as myosin
heavy chain (MyHC) and severalmuscle speciﬁc microRNAs (Kim et al.,
2006; Rao et al., 2006).
Here, we show that FGF signalling through ERK MAP kinase
delayed expression of miR-1, miR-206, and miR-133 in C2C12 cells
undergoingmyogenic differentiation. Using gain-of-function and loss-
of-function approaches in chicken and mouse embryos we demon-
strate that ectopic expression ofMyf-5,MyoD, myogenin andMRF-4 in
the developing chicken neural tube induced the expression of distinct
muscle speciﬁc microRNAs while the lack ofMyf-5 resulted in a loss of
miR-1 and miR-206 expression in developing somites. In contrast, the
absence of MyoD had no discernable effect on expression of these
microRNAs.
Materials and methods
C2C12 cell culture and transfection
Mouse C2C12 cells were maintained at sub-conﬂuent densities in
DMEM supplemented with 10% heat-inactivated FBS (growth med-
ium; GM) and 1% penicillin/streptomycin. Myogenic differentiation
was induced by changing the growthmedium of sub-conﬂuent cells to
DMEM containing 2% heat-inactivated horse serum and 1% penicillin/
streptomycin (differentiation medium; DM). Transfections werecarried out using Lipofectamine™ 2000 Transfection Reagent (Invi-
trogen) according to the manufacturer's instructions. 300 ng plasmid
DNA was used. Cells were incubated in transfection reagent–DNA
complexes for 5 h. Afterwards, the cells were incubated in GM or DM
depending upon the experiment, for 1–5 days and then harvested for
RNA isolation. Transfection efﬁciency was quantiﬁed by counting GFP
positive cells and found to be about 75%.
RNA isolation and Northern blotting
Total RNA was isolated from C2C12 cells as follows. Cells were
washed twice with PBS, collected in guanidinium solution, trans-
ferred into an eppendorf tube and vortexed until lysis was complete.
2 M sodium acetate (pH 4) was added, followed by addition of 1
volume of acidic phenol (ph 4.5) and 0.2 volumes of chloroform/
isoamyl alcohol. The samples were incubated on ice for 15 min and
centrifuged at 13000 rpm for 15 min at 4 °C. The top phase was
transferred into a new tube and RNA was precipitated with 2.5
volumes of 100% ethanol at −80 °C. After centrifugation at
13000 rpm for 15 min at 4 °C the pellet was washed with 70%
ethanol, air-dried and resuspended in 20 μl DEPC-water. Northern
blots were done as described in Sweetman et al. (2006). Brieﬂy,
50 μg of total RNA was separated on 15% denaturating polyacryla-
mide gel electrophoresis (PAGE), run at 80 V for approximately 2 h,
and visualized on a UV trans-illuminator after staining with 1 μg/ml
ethidium bromide solution in 1×MOPS for 10 min. RNA was
transferred to Hybond NX membrane (Amersham Biosciences) by
semi-dry blotting using 20 V for 2 h. RNA was cross-linked using
EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide in 12.5 M 1-
methylimidazole) at 60 °C for 2 h. The sequences of the probes were
as follows, miR-1 probe: TACATACTTCTTTACATTCCA; miR-133c
probe: GCAGCTGGTTGAAGGGGACCAA; miR-206 probe: CCACA-
CACTTCCTTACATTCCA. Probes were end-labelled with γ-32P-ATP
using T4 polynucleotide kinase (Invitrogen) and puriﬁed on a
Sephadex G-25 column (Amersham Biosciences). Blots were pre-
hybridised in UltraHyb Oligo (Ambion) and hybridised overnight at
37 °C in a hybridisation oven. Membranes were washed twice with
0.2×SSC/0,5% SDS at 37 °C for 30 min and then exposed at room
temperature to Fuji Bass cassette 2040 (Fuji). Next, the membranes
were stripped and hybridised with probe detecting the U6 small
nuclear RNA.
Generation of MRF expression constructs
Chicken MRF cDNAs were cloned by RT-PCR using template from
4 day old embryos and Phusion DNA polymerase (NEB) and standard













PCR products were A-tailed with Taq polymerase, cloned into
pGEM-T-Easy (Promega), sequenced and subcloned into pCAβ-IRES-
GFP using the appropriate restriction enzymes.
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Expression plasmids were grown in Escherichia coli DH5α and
isolated using a high-speedmidi-kit (Qiagen). DNA for electroporation
was further puriﬁed using a PCR puriﬁcation kit (Qiagen) and eluted to
give a concentration of 1 mg/ml. DNA was mixed with fast green to a
ﬁnal concentration of 0.05% and injected using glass capillary needles
and a femtojet microinjector (Eppendorf) as described (Yue et al.,
2008). Injections into the neural tube were performed in Hamburger–
Hamilton (HH) stage 14 (Hamburger and Hamilton, 1951) embryos in
ovo. Electroporation was done using a TSS20 Ovodyne Electroporator
(Intracel) delivering ten 50 ms pulses of 30 V.
Whole mount in situ hybridisation
Detection of MRFs was as described (Smith et al., 2005). Dual-DIG-
labelled LNA probes were obtained from Exiqon and hybridised as
described in (Sweetman et al., 2006). LNA probes were hybridised and
washed at the following temperatures, miR-1: 42 °C; miR-206: 50 °C
and miR-133: 65 °C. Double in situs were ﬁrst hybridised with Myf-5
probes at 65 °C, washed at 65 °C, then re-hybridised with miR-206 at
50 °C and washed at 50 °C.
Results
Muscle speciﬁc microRNAs are expressed during somite myogenesis
Weexamined the spatio-temporal expression ofmiR-1,miR-206 and
miR-133 during chicken embryo development using whole mount LNA
in situ hybridisation. Both, miR-1 and miR-133 were expressed in post
mitotic cells in the somite myotome (Figs. 2A, C) similar to the
expression pattern of miR-206 (Fig. 2B) (Sweetman et al., 2006),
although the expression of miR-1 and miR-133 was restricted to the
more anterior and therefore more differentiated somites compared to
miR-206. At HH stage 20 the posterior expression boundary for miR-1
was at the level of the fore limb, for miR-133 at the level of the ﬂank and
for miR-206 at hind limb level (Figs. 2A–C, black arrowheads).
Furthermore, miR-1 and miR-133 were expressed in the heart while
miR-206was not (Figs. 2A–C). Using LNA in situ hybridisationwe cannot
determine which miR-133 transcripts are expressed in the heart. It is
likely that miR-133b, which is generated from the same primary
transcript asmiR-206, is only expressed in skeletal muscle. However we
cannot exclude the possibility that differential processing of this
primary transcript could produce miR-133b expression in cardiac cells
in the absence of miR-206. There is precedence for this scenario, since it
has been shown that miR-1-2 and miR-133a-1 can be generatedFig. 2. Expression ofmuscle speciﬁc microRNAs duringmyogenesis. (A–C)Wholemount
in situ hybridisation using LNA oligos in HH stage 20 chicken embryos showing
expression of miR-1 (A), miR-206 (B) and miR-133 (C). Arrowheads show the most
posterior somite with detectable staining. my — myotome, ht — heart.independently from the same primary transcript, in at least some
circumstances (Liu et al., 2007).
FGF signalling mediated by ERK MAP kinase suppresses the expression of
microRNA miR-1, miR-206 and miR-133
To establish the expression proﬁle of miR-1, miR-206 and miR-133
during differentiation of C2C12 cells Northern blot analysis was
performed (Fig. 3A). miR-1, miR-133, and miR-206 were readily
detected 2 days (D2) after transfer into differentiation medium (DM)
(Fig. 3A). In contrast, cells grown in high serum (GM) did not reveal
signs of myogenic differentiation as indicated by the lack of MyHC
expression and failed to show expression of muscle speciﬁc microRNA
until day 4 when cells became conﬂuent (Fig. 3E).
Since FGF ERK MAP kinase signalling attenuates miR-206 expres-
sion in somites of developing chicken embryos (Sweetman et al.,
2006), we wanted to examine the regulation of microRNAs during
myogenic differentiationmore closely in C2C12 muscle cells (Figs. 3B–
D, F–H). Addition of recombinant FGF-4 or FGF-8 to DM signiﬁcantly
delayed the differentiation process resulting in the absence of any
myotubes after 5 days of incubation. Concomitantly, the expression of
muscle speciﬁcmicroRNAswas delayed and robust expressionwas not
observed until day four (D4) (Figs. 3B, C). This result was consistent
with the inhibitory effects of FGF-beads on miR-206 expression in
somites (Sweetman et al., 2006).
Similarly, expression of a constitutively active form of MEK, MEKEE
(Smith et al., 2005) delayed myogenic differentiation in DM, as shown
by MF20 immunostaining, and simultaneous expression of muscle
speciﬁc microRNAs (Fig 3D). Next, C2C12 cells grown in GM were
treated with a pharmacological inhibitor SU5402, known to block FGF
receptor activation. Interestingly, expression of muscle speciﬁc
microRNAs was enhanced under these conditions and was already
detected at day two (D2) (Fig. 3F) indicating a direct regulation of the
expression of muscle speciﬁc microRNA by FGF-signalling; myotube
formation was evident by day three (D3) (not shown).
To determine which downstream effectors of FGF signalling
mediated the repression of microRNA expression under GM condi-
tions, C2C12 cells were treated with PD184352, a known MEK
inhibitor (Sebolt-Leopold et al., 1999). This led to early expression of
muscle speciﬁc microRNAs, with particularly strong effects on miR-1
and miR-133 (Fig. 3G), when compared to control cultures (Fig. 3E).
Finally, we transfected C2C12 cells, cultured in GM, with the MKP3
phosphatase, a speciﬁc inhibitor of ERK MAP kinase (Groom et al.,
1996). This resulted in premature expression of muscle speciﬁc
microRNAs and myogenic differentiation (Fig. 3H). We provide a
quantitative representation of the relative amounts of signal normal-
ized to U6 loading control in Supplementary Fig. 1.
To conﬁrm that the altered expression of miRs corresponded with
changes in differentiation, cells were stained with the MF20 antibody
to detect sarcomeric myosin heavy chain (MyHC) expression. In all
cases delayed miR expression correlated with reduced MyHC expres-
sion, while early expression correlated with increased expression (see
side panels in Fig 3).
Myogenic regulatory factors, MRFs, induce myogenic genes and ectopic
microRNA expression in the neural tube
To determine if muscle speciﬁcmicroRNA expression can be induced
in vivo by directed expression of MRFs we cloned chicken MRFs (Myf5,
MyoD, myogenin and Mrf-4) into pCAβ-IRES-GFP for expression in
embryos. This vector produces both the gene of interest and GFP from
the same backbone and thus allows easy determination of electropora-
tion efﬁciency. After electroporation into the chicken neural tube all
embryos expressed GFP. To conﬁrm that functional MRF proteins were
produced by the plasmid, we ﬁrst examined whether MRFs could
activate each other's expression (Fig. 4). Electroporation of pCAβ-Myf-5-
Fig. 3. Regulationofmuscle speciﬁcmicroRNAs by FGF signalling inC2C12 cells. (A)MicroRNAexpressionbeginning at day2 following transfer todifferentiationmedium (DM). (B–D)Delayed
microRNAexpression in cellsgrown inDMfollowing treatmentwith10ng/ml FGF4 (B), 20ng/ml FGF8 (C) or transfectionwithMEKEE (D). (E) ExpressionofmicroRNAs ingrowthmedium(GM)
ﬁrst detected at day 4. (F–H) Induction ofmicroRNAexpression inGM following treatmentwith 20 μMSU5402 (F),10 μMPD184352 (G) or transfectionwithMKP3 (H). Panels adjacent to blots
show C2C12 cells at 1 and 5 days following treatment. Green staining shows MF20 positive cells expressing sarcomeric myosin which have undergonemyogenic differentiation.
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neural tissue (Fig. 4A). Embryos electroporated with pCAβ-MyoD-IRES-
GFP in the neural tube expressed ectopic myogenin (Fig. 4B), and
expression of pCAβ-Mgn-IRES-GFP induced ectopic MyoD and Mfr-4
(Fig. 4C). Finally, pCAβ-Mrf-4-IRES-GFP expression induced myogenin
(Fig. 4D). These results conﬁrmed that all MRF expression plasmids
produced functional proteins.
Next, we investigated the ability of MRFs to activate expression of
muscle speciﬁc microRNAs in neural tissue. We found that pCAβ-Myf-
5-IRES-GFP electroporation led to expression of both miR-1 and miR-
206 with high efﬁciency (Fig. 5A). Similarly, pCAβ-Mgn-IRES-GFP
resulted in miR-1 and miR-206 expression in the neural tube (Fig. 5C).
In contrast, pCAβ-MyoD-IRES-GFP and pCAβ-Mrf-4-IRES-GFP induced
expression of miR-206 but not miR-1 (Figs. 5B, D). Activation of miR-206 expression by Mrf-4 was very inefﬁcient, with 45% of embryos
showing low levels of detectable expression (Fig. 5D).
To conﬁrm that ectopic expression of microRNAs in the neural tube
co-localised with ectopic MRF expressionwe performed double in situ
hybridisation forMyf-5 and miR-206 on embryos electroporated with
pCAβ-Myf-5-IRES-GFP in the neural tube. Transverse sections of these
embryos clearly revealed the presence of miR-206 in a subset of cells
expressing Myf-5 (Fig. 5E).
Muscle speciﬁc microRNA expression is downregulated in somites of
Myf-5(−/−) but not MyoD(−/−) null mouse embryos
The directed expression of MRFs indicated that Myf-5 and
myogenin are sufﬁcient to promote expression of endogenous miR-1
Fig. 4. Expression of MRFs in the neural tube activates muscle speciﬁc gene expression. (A) Electroporation of Myf5, (B) MyoD, (C) Myogenin and (D) MRF4. In situ hybridisationwere
performed for Myf5, MyoD, Myogenin and MRF4 as indicated above each column. Arrows show ectopic expression detected in the neural tube. The number of embryos with ectopic
expression out of the total number of surviving embryos electroporated is shown in each panel. nt — neural tube, so — somite. Red asterisks show endogenous staining in somites.
495D. Sweetman et al. / Developmental Biology 321 (2008) 491–499and miR-206 loci in neural tissue, while MyoD and Mrf-4 were able to
activate miR-206, but not miR-1 expression. To determine the effects
of loss of function of MRFs on muscle speciﬁc microRNA expression,
we examined the expression of miR-1 and miR-206 in embryoshomozygous for null alleles of Myf-5 or MyoD compared to expression
in wild type or heterozygous embryos (Fig. 6).
As expected, expression of both miR-1 and miR-206 was detected
in the myotomes of wild type (Figs. 6A, B) and heterozygous Myf-5(+/−)
Fig. 5.MRFs can activate microRNA expression in the neural tube. (A) Electroporation of Myf5, (B) MyoD, (C) Myogenin and (D) MRF4. In situ hybridisation was performed for miR-1
and miR-206 as indicated above each column. Arrows show ectopic expression in the neural tube. The number of embryos with ectopic expression out of the total number of
surviving embryos electroporated is shown in each panel. (E) Transverse section of embryo electroporated with Myf5 in neural tube followed by double in situ hybridisation for Myf5
(red) and miR-206 (blue). Arrow shows ectopic expression of both Myf5 and miR-206. nt — neural tube, so — somite. Red asterisks show endogenous staining in somites.
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expression in chicken somites, miR-206 was more robustly expressed
and was detected in more posterior, immature somites, when
compared to miR-1. At E10.5, miR-206 was seen in somites at hind
limb level (somites 26–29) and miR-1 was detected in ﬂank level
somites (somites 23–26). Importantly, we did not detect expression of
either miR-1 or miR-206 in Myf-5(−/−) null embryos (Figs. 6E, F)
whereas MyoD(−/−) null embryos retained robust expression of both
miR-1 andmiR-206 (Figs. 6I, J). These results demonstrated that Myf-5Fig. 6.miR-1 and miR-206 expression is lost in Myf-5(−/−) null mice. LNA in situ hybridisation
wild type, genotypes are indicated on each panel. Expression of miR-1 (A, C, E, G, I) and miR-2
or MyoD(−/−) (I, J) embryos. lb — limb bud, tb — tail bud, so — somite. Arrowheads mark theis required for the activation of miR-1 and miR-206 expression in the
myotome of developing somites, yet MyoD is dispensable.
Discussion
Our results illustrate that miRNAs are part of the differentiation
programme of muscle cells. In particular, we show that the regulation
of miR-1, miR-206 and miR-133 by FGF ERK MAP kinase signalling is
conserved in myogenic C2C12 cells as well as in the embryo. Wewas performed on Myf-5(−/−) and MyoD(−/−) mouse mutants, heterozygous animals and
06 (B, D, F, H, J) in either wild type (A, B), Myf5(+/−) (C, D), Myf5(−/−) (E, F), MyoD(+/−) (G, H)
most anterior and posterior somites expressing microRNAs.
497D. Sweetman et al. / Developmental Biology 321 (2008) 491–499propose that FGF ERKMAP kinase inhibition of miR expression acts by
abrogating MRF activity and, consistent with this, we demonstrate
that MRF transcription factors are sufﬁcient to activate microRNA
expression in vivo. In addition, our analyses reveal distinct roles of
individual MRFs to induce microRNA expression in the chicken neural
tube. Finally, investigation of mouse mutants suggests a previously
unrecognized requirement of Myf-5 for the expression of miR-1 and
miR-206 in developing somites.
FGF ERK MAP kinase regulates muscle speciﬁc microRNAs during C2C12
cell myogenesis
Implantation of FGF4 or FGF8 beads adjacent to developing
somites led to down-regulation of both miR-206 and MyoD (Smith
et al., 2005; Sweetman et al., 2006), which raised the question
whether FGF-mediated inhibition of muscle speciﬁc microRNAs is a
general regulatory phenomenon. To explore this possibility we
utilized C2C12 muscle cells, a well characterised myogenic cell line
derived from adult mouse satellite cells, that undergoes myogenic
differentiation under deﬁned conditions (Portier et al., 1999). We
found that in low serum conditions (DM) addition of FGF-4 or FGF-8
was sufﬁcient to delay the onset of muscle speciﬁc microRNA
expression (Figs. 3B, C), while in high serum (GM) FGF receptor
inhibition, using the pharmacological inhibitor SU5402, led to early
differentiation (Fig. 3F). A number of pathways providing both positive
and negative signalling cues for myogenic differentiation could be
affected by these manipulations (de Alvaro et al., 2005; Kuwahara et
al., 2005; Lluis et al., 2006). However, with increased density the cells
differentiated eventually and formedmyotubes, which is probably due
to the well-documented down-regulation of FGF-receptors in con-
ﬂuent muscle cells in culture (Olwin and Hauschka, 1988). Consistent
with this observation, expression of muscle speciﬁc microRNA was
detected in the presence of FGF, albeit delayed when compared to the
normal expression proﬁle (Figs. 3A–C). Speciﬁc activators of ERK MAP
kinase also led to delayed microRNA expression (Fig. 3D), while ERK
inhibitors had the opposite effect and led to earlier expression of
muscle speciﬁc microRNAs even under high serum (GM) conditions
(Figs. 3G, H). These ﬁndings suggest that FGF ERK MAP kinase
signalling promotes proliferation and inhibits differentiation of
myogenic cells most likely through ERK-mediated inhibition of MRF
activities described by several groups (Bennett and Tonks, 1997;
Kontaridis et al., 2002; Pena et al., 2000; Perry et al., 2001). Here we
characterise muscle speciﬁc microRNAs as new targets of this
regulatory network.
Differential regulation of microRNAs by MRFs in the developing chicken
neural tube
The loss of muscle microRNA expression following FGF treatment
of somites or C2C12 cells was likely to be indirect, since FGF treatment
leads to loss of MyoD as well as miR-206 in embryos (Smith et al.,
2005; Sweetman et al., 2006). Furthermore, MyoD and myogenin are
known to bind regions upstream of miR-1 (Rao et al., 2006). Thus, we
examined whether the effects of FGF were mediated via the MRF
family of transcription factors. Ectopic expression in the developing
chicken neural tube has previously revealed the myogenic potential of
Pax3 (Maroto et al., 1997) and Myf5 and MyoD (Delﬁni and Duprez,
2004). Interestingly, ectopic expression of MRFs revealed unexpected
differences in the ability of MRFs to activate expression of different
microRNAs (Figs. 4, 5). We found that Myf-5 induced both miR-1 and
miR-206 together with MyoD, myogenin and Mrf4 indicating that
Myf-5 is able to activate the whole repertoire of MRFs and microRNAs
(Figs. 5A, 4A). We were not able to distinguish between the
electroporated and the endogenous Myf-5 transcripts, since both
were from avian origin. Therefore, we could not determine whether
Myf-5 is able to induce its own expression, although extensivecharacterisation of the Myf-5 locus in transgenic mice suggests that it
cannot (Carvajal et al., 2001; Carvajal et al., 2008). In the neural tube,
myogenin had a similar activity as Myf-5 and induced MyoD, Mrf-4,
miR-1 and miR-206 but clearly did not induceMyf-5 expression (Figs.
4C, 5C). Interestingly, ectopic expression of either MyoD or Mrf-4 led
to ectopic expression of onlymyogenin andmiR-206 (Figs. 4B, D, 5B, D).
These results demonstrate that even when expressed at high levels
there seem to be differences in the ability of the MRFs to activate
microRNA genes in the non-myogenic cells of the developing chicken
neural tube. Although our data implies a role for the MRFs in the
activation of miR gene expression, a single MRF is unlikely to be
sufﬁcient. Closer analysis ofMyf5 electroporation into the neural tubes
shows that only a subset of the cells expressing Myf5 undergoes
myogenic differentiation and activates microRNA expression. This
implies additional requirements found in only some of the electro-
porated neural cells, for example, the levels of Myf5 may be sufﬁcient
in only a subset of cells and/or additional MRFs have to be expressed.
The fact that MyoD and Myogenin are known to bind to putative
regulatory regions of miR-1 suggests that the induction of ectopic
microRNA expression byMRFs may indeed be direct (Rao et al., 2006).
ChIP on Chip experiments revealed binding of both MyoD and
myogenin to miR-1 upstream regions in the mouse genome. However,
it is difﬁcult to determine whether the effects we observed can be
directly attributed to the MRF that was electroporated since other
MRFs were induced, although their expression tended to be weaker
(Fig. 4). Nevertheless, it is noteworthy that the differences observed
between Myf-5/myogenin and MyoD/Mrf-4 with respect to their
ability to induce microRNA gene expression (Fig. 5A–C) strongly
correlated with their ability to induce the network of myogenic
regulators.
Mutant mice indicate a requirement of Myf-5 for muscle speciﬁc
microRNA expression in somites
Overexpression of MRFs in the neural tube suggested that Myf-5
and myogenin were sufﬁcient to elicit ectopic expression of both miR-
1 and miR-206, whereas MyoD was able to induce only miR-1. This
observation was consistent with the considerable redundancy of
function that is known for MRFs. Analysis of Myf-5 and MyoD mutant
mice indicated a surprising speciﬁc requirement of Myf-5 for miR-1
and miR-206 expression (Fig. 6). At E11.5 both miR-206 and miR-1
expression was almost entirely absent in somites of Myf-5(−/−) null
embryos, suggesting that other MRFs, including myogenin, which are
expressed in these mice (Rudnicki et al., 1993) cannot compensate for
the loss of Myf-5. In contrast, embryos lacking MyoD(−/−) showed an
apparently normal expression of both microRNAs. This is particularly
notable given that both MyoD and Myf-5 null animals will produce
morphologically normal skeletal muscle, as these transcription
factors are able to compensate for each other during development
(Braun et al., 1992; Rudnicki et al., 1992). Interestingly, this functional
redundancy seems not to apply to the expression of miR-1 and miR-
206 and this suggests a number of possibilities. It is possible that
miR-1 and miR-206 do not have an essential function during
myogenesis. Alternatively, Myf5 mutants, which lack miR-1 and
miR-206 expression, might suffer from a yet undetected embryonic
phenotype. Finally, other microRNAs may compensate for the lack of
miR-1 and miR-206 in Myf5 mutants. Further identiﬁcation of
microRNAs and characterisation of their expression patterns may
well reveal other miRs in muscle, which could fulﬁl this role.
Owing to the functional compensation between the MRFs in
knockout mouse models (Braun et al., 1992; Kassar-Duchossoy et al.,
2004; Rawls et al., 1995; Rudnicki et al., 1992) their distinct biological
activities have only recently been recognized. Different MRFs have
been shown to be important in different myogenic lineages
(Tajbakhsh, 2005) and there is a speciﬁc requirement for Myf-5 in
adult homeostasis and regeneration (Gayraud-Morel et al., 2007;
498 D. Sweetman et al. / Developmental Biology 321 (2008) 491–499Ustanina et al., 2007). Thus, it is tempting to speculate that miR-1 and
miR-206 are potential mediators of Myf5 in these processes.
Myogenesis has been reported to be delayed in Myf-5(−/−) mice,
therefore, it is possible that expression of miR-1 and miR-206 is
eventually restored (Braun et al., 1992). However, we have examined
Myf5(−/−) embryos as late as E14 and there was no expression of miR-
206 detected in somites at that stage (data not shown). This suggests
that loss of miRs in E11.5 Myf5(−/−) embryos is not just the result of
delayed differentiation.
It was shown recently that in mouse embryos where all Myf5
expressing cells have been ablated a population of MyoD positive cells
is able to compensate and generate apparently normal muscle
(Gensch et al., 2008; Haldar et al., 2008). This raises the possibility
that miR-1 and miR-206 are only expressed in Myf5-dependant
lineages and that Myf5 independent muscle lineages may have
entirely separate regulatory mechanisms either involving different
microRNAs or microRNA independent regulation. The conditional
deletion of Dicer resulted in skeletal muscle hypoplasia, clearly
demonstrating a role for microRNAs in both embryonic and postnatal
development (O'Rourke et al., 2007).
A number of microRNA targets are predicted through different
algorithms and a few of these have been experimentally conﬁrmed.
These include Connexin-43 (Anderson et al., 2006), HDAC4, Id1-3,
DNA polα (Kim et al., 2006), follistatin and Utrophin (Rosenberg et
al., 2006), which are targeted by miR-1/206, and the HERG K+
channel (Xiao et al., 2007) and SRF (Chen et al., 2006), which are
targets of miR-133. In addition, the muscle speciﬁc microRNAs have
been implicated in muscle hypertrophy and a mouse model of
muscular dystrophy (McCarthy and Esser, 2007;McCarthy et al., 2007).
How the interactions between upstream regulators of microRNAs
and the targets of miR activity lead to muscle differentiation during
development and the maintenance of healthy muscle physiology and
function will require further investigation.
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